UTMB researchers find Pfizer vaccine effective against new COVID-19 strain

Study results showed that the new COVID-19 mutation alone does not compromise the Pfizer vaccine’s neutralizing activity against the virus, which is good news for the vaccine. (Courtesy Adobe Stock)
Study results showed that the new COVID-19 mutation alone does not compromise the Pfizer vaccine’s neutralizing activity against the virus, which is good news for the vaccine. (Courtesy Adobe Stock)

Study results showed that the new COVID-19 mutation alone does not compromise the Pfizer vaccine’s neutralizing activity against the virus, which is good news for the vaccine. (Courtesy Adobe Stock)

A team of researchers from Pfizer and The University of Texas Medical Branch at Galveston has found that Pfizer’s COVID-19 vaccine is not compromised by the coronavirus mutation seen in strains originating from the United Kingdom, according to a Jan. 11 UTMB media release.

The team worked on the first completed study investigating whether the new virus strain affects the vaccine’s efficacy, according to the media release. Harris County Public Health conducted contact tracing last week for a resident who tested positive for the new COVID-19 variant; that case was the first in the county and in the state, officials said Jan. 7.

The UK mutation, known as N501Y, is of particular concern because this mutation increases spike binding to the cellular receptor for infecting cells, said Xuping Xie, an assistant professor at UTMB and the first author of the study, in the release. While the vaccine was determined to still be effective against this particular variant, Xie added that more studies are necessary.

“Besides this mutation, other mutations—particularly the E484K mutation from the South African strain, which has been previously shown to make the virus resistant to antibody therapy—should also be studied,” Xie said in the release. “More importantly, viruses containing the complete set of spike mutations from the new strains should be examined.”

The rapidly spreading strains of the virus from the U.K. and South Africa have raised alarms related to vaccine efficacy, therapeutic antibody potency, virus transmission and illness severity, said Pei-Yong Shi, a professor at the UTMB Department of Biochemistry and Molecular Biology and the senior author of the study, in the release.

The study involved using a panel of clinical trial serum specimens to test if the N501Y mutation affects the vaccine-induced antibody activity against the virus, Shi added. Results showed the mutation alone does not compromise the vaccine’s neutralizing activity against the virus, which is good news for the vaccine, he said in the release.

Researchers should use the mutant viruses to investigate the effects of mutations on viral transmission and disease development, said Scott Weaver, the director of the UTMB Institute for Human Infections and Immunity and a co-author of the study.

“Using COVID-19 animal models, we should quickly test if the newly emerged strains are indeed more transmissible, as indicated by epidemiological results,” he said in the release. “If this is the case, we should be able to identify which specific [mutation or mutations are responsible] for the enhanced transmission and its mechanism.”

In total, six UTMB researchers and four Pfizer researchers collaborated on the study, which received funding from Pfizer, grants from the National Institutes of Health and philanthropic support from six different foundations, per the release. The full text of the study can be found here.

By Colleen Ferguson
A native central New Yorker, Colleen Ferguson worked as an editorial intern with the Cy-Fair and Lake Houston | Humble | Kingwood editions of Community Impact before joining the Bay Area team in 2020. Colleen graduated from Syracuse University in 2019, where she worked for the campus's independent student newspaper The Daily Orange, with a degree in Newspaper and Online Journalism from the S.I. Newhouse School of Public Communications and a degree in Spanish language and culture. Colleen previously interned with The Journal News/lohud, where she covered the commute in the greater New York City area.



One local health system leader said he expects everyone, including those under age 65, will have access to the vaccine within the next 90 days. (Courtesy Adobe Stock)
Houston-area health system leaders talk progress, hurdles during COVID-19

Officials from CHI St. Luke’s Health and UTMB Health said community members must remain vigilant as case counts climb but that they expect the current surge to peak by early February.

During a North Houston Association meeting Jan. 20, Jazz Hamilton—first vice president with the Retail Brokerage Services Group for CBRE—discussed how the future of retail will likely be shaped by the conveniences to which consumers have become accustomed amid the coronavirus pandemic. (Ronald Winters/Community Impact Newspaper)
Pandemic-induced retail conveniences are here to stay, official says

According to Jazz Hamilton, first vice president with the Retail Brokerage Services group for CBRE, between January and November of 2020, consumers spent almost $550 billion online—a 33% increase from 2019.

The estimated number of active COVID-19 cases in Harris County has surpassed 50,000, reaching 51,362 as of the most recent data Jan. 20, according to the Harris County Public Health Department. (Community Impact staff)
Harris County coronavirus count: Active cases top 50,000

See the latest trends on COVID-19 in Harris County.

More than 3,200 new COVID-19 cases have been reported in Galveston County since Jan. 6. (Courtesy Adobe Stock)
Galveston County adds 38 COVID-19 deaths in 2 weeks

Nearly 30% of the total county coronavirus cases are considered active as of Jan. 20.

In addition to vaccine hubs, there are also smaller community vaccine providers throughout Texas, such as pharmacies, that may also have the vaccine available. (Eva Vigh/Community Impact Newspaper)
EXPLAINED: When, where and how Texans can receive the COVID-19 vaccine

As Texas is still in the early stages of rolling out the COVID-19 vaccine, many Texans are still unsure about, where, when and how they can get inoculated.

The barbecue eatery is the second Killen's Restaurant Group venture to launch in The Woodlands area. (Courtesy Killen's Barbecue)
Killen's Barbecue opens in The Woodlands and more Houston-area news

Read the latest business and community news from the Houston area.

Mayor Turner and the honor guard.
Houston joins nationwide coronavirus memorial, lights landmarks

The memorial was planned as a component of President-elect Joe Biden and Vice President-elect Kamala Harris' inauguration.

If the park becomes a hub, it would join two others currently established in the county: One is at the University of Texas Medical Branch hospital in Galveston, and the other hub is at the Galveston County Health District. The health district will offered the Moderna COVID-19 vaccine to those 65 years of age and older by appointment only after receiving 1,000 additional doses; appointments were filled within hours. (Eva Vigh/Community Impact Newspaper)
NEW: League City's Walter Hall Park closed to become potential mass vaccination site

Two other vaccine hubs are currently established in Galveston County, neither of which are offering new vaccine appointments the week of Jan. 18.

Galveston County sees slow rollout of COVID-19 vaccine

With COVID-19 case counts rising at record-high rates in Galveston County, Bay Area residents are awaiting additional vaccine doses as they trickle in.

22 restaurants that opened in the Bay Area in 2020, 1 coming soon in 2021

Here is a list of the restaurants that opened in the Bay Area over the past year.

Yachty Gras (Courtesy Yachty Gras Foundation)
TO-DO LIST: 7 Bay Area events in January and February

Here are Bay Area events worth attending in January and February.

Learn about League City Orange Groves, January's featured neighborhood

League City Orange Groves is located near I-45 with quick access to schools, shopping and dining.